A possible relationship between protein kinase C activation and impaired receptor-mediated endothelium-dependent relaxation in diabetes mellitus was examined in isolated aorta from normal rabbit exposed to elevated glucose. Aorta treated for 10 min with 4-phorbol 12-myristate 13-acetate (PMA), a protein kinase C activator, showed decreased relaxations to the endothelium-dependent vasodilator, acetylcholine, similar to normal aorta exposed to elevated glucose (22 and 44 mM) for 6 h. Relaxations to the receptor-independent endothelium-dependent vasodilator, A23187, and those caused by the direct smooth muscle vasodilator, sodium nitroprusside, were unaffected by treatment with PMA or exposure to elevated glucose. Indomethacin increased relaxations to acetylcholine of aorta treated with PMA indicating a role for vasoconstrictor prostanoids. PMA caused a significant increase in basal and acetylcholine-stimulated release of vasoconstrictor prostanoids including thromboxane A2 from aortic segments with, but not without endothelium. Protein kinase C inhibitors, H-7 or sphingosine, restored the abnormal acetylcholine-induced relaxations as well as suppressed the abnormal release of prostanoids in aorta exposed to elevated glucose. These findings suggest that the dysfunction of receptor-mediated endothelium-dependent relaxation associated with exposure to elevated glucose is due to increased production of vasoconstrictor prostanoids by the endothelium as a consequence of protein kinase C activation.
B Tesfamariam, M L Brown, R A Cohen
Title and authors | Publication | Year |
---|---|---|
Endothelial Dysfunction and Diabetes: Effects on Angiogenesis, Vascular Remodeling, and Wound Healing
GK Kolluru, SC Bir, CG Kevil |
International Journal of Vascular Medicine | 2012 |
The Role of Glucosamine-Induced ER Stress in Diabetic Atherogenesis
DR Beriault, GH Werstuck |
Experimental Diabetes Research | 2012 |
Vascular effects of intravenous intralipid and dextrose infusions in obese subjects
AR Gosmanov, DD Smiley, L Peng, J Siquiera, G Robalino, C Newton, GE Umpierrez |
Metabolism: clinical and experimental | 2012 |
Fibrosis and heart failure
AM Segura, OH Frazier, LM Buja |
Heart Failure Reviews | 2012 |
Systemic hemodynamic function in humans with type 1 diabetes treated with protein kinase Cβ inhibition and renin–angiotensin system blockade: a pilot study
DZ Cherney, HN Reich, JW Scholey, V Lai, C Slorach, B Zinman, TJ Bradley |
Canadian Journal of Physiology and Pharmacology | 2012 |
Muscle
ML Martin, SL Belmonte, R Ram, FA Kamal, BC Blaxall |
Muscle | 2012 |
Cyclophilin-A: a potential screening marker for vascular disease in type-2 diabetes
S Ramachandran, CC Kartha |
Canadian Journal of Physiology and Pharmacology | 2012 |
Diabetes and hypertension: the bad companions
E Ferrannini, WC Cushman |
The Lancet | 2012 |
Pathophysiology of diabetic erectile dysfunction: potential contribution of vasa nervorum and advanced glycation endproducts
S Cellek, NE Cameron, MA Cotter, A Muneer |
International Journal of Impotence Research | 2012 |
Role of oxidative stress in diabetes-mediated vascular dysfunction: Unifying hypothesis of diabetes revisited
SW Schaffer, CJ Jong, M Mozaffari |
Vascular Pharmacology | 2012 |
Association of the genetic variants of endothelial nitric oxide synthase gene with angiographically defined coronary artery disease and myocardial infarction in South Indian patients with type 2 diabetes mellitus
P Narne, KC Ponnaluri, S Singh, M Siraj, M Ishaq |
Journal of Diabetes and its Complications | 2012 |
The effect of direct renin inhibition alone and in combination with ACE inhibition on endothelial function, arterial stiffness, and renal function in type 1 diabetes
DZ Cherney, JW Scholey, S Jiang, R Har, V Lai, EB Sochett, HN Reich |
Diabetes care | 2012 |
Increased Atherothrombotic Burden in Patients with Diabetes Mellitus and Acute Coronary Syndrome: A Review of Antiplatelet Therapy
K Balasubramaniam, GN Viswanathan, SM Marshall, AG Zaman |
Cardiology Research and Practice | 2012 |
Perindopril protects against streptozotocin-induced hyperglycemic myocardial damage/alterations
BM Patel, SS Agarwal, SV Bhadada |
Human & Experimental Toxicology | 2012 |
Diabetic cardiomyopathy: Pathophysiological mechanisms and cardiac dysfuntion
BR Goyal, AA Mehta |
Human & Experimental Toxicology | 2012 |